4 Healthcare Stock Stories to Promote Investment Wellness for Monday
CVS Caremark Corp. (NYSE:CVS): Closing price $58.20
On Monday, Moody’s Investors Service upgraded CVS Caremark Corporation’s senior unsecured rating from Baa2 to Baa1. Concurrently, CVS Caremark’s Commercial Paper rating was affirmed at Prime-2 with the rating outlook as stable. The upgrade reflects Moody’s belief that CVS Caremark’s solid growth in operating income and recent improvement in operating margin is sustainable and also that the trend will continue.
Senior Credit Officer Maggie Taylor at Moody’s commented that, “CVS Caremark’s earnings will continue to benefit from numerous positive industry trends including; the solid growth in specialty pharmacy, increasing generic utilization rates, further branded drugs coming off patent, and the high growth in the United States population over the age of 65.”